{"id":12079,"date":"2009-09-18T18:00:00","date_gmt":"2009-09-18T18:00:00","guid":{"rendered":""},"modified":"2009-09-18T18:00:00","modified_gmt":"2009-09-18T18:00:00","slug":"vartojamo-didelio-vaistu-kiekio-poveikis-virskinamajam-traktui","status":"publish","type":"post","link":"https:\/\/www.pasveik.lt\/lt\/naujausi-medicinos-straipsniai\/vartojamo-didelio-vaistu-kiekio-poveikis-virskinamajam-traktui\/12079\/","title":{"rendered":"Vartojamo didelio vaist\u0173 kiekio poveikis vir\u0161kinamajam traktui"},"content":{"rendered":"<p style=\"text-align: justify\"><span lang=\"LT\" style=\"font-family: Arial; mso-ansi-language: LT\"><font size=\"2\">Vyresnio am\u017eiaus pacientai daug da\u017eniau serga \u012fvairiomis ligomis ir gydosi keletu skirting\u0173 vaist\u0173. Polifarmacija gali pasireik\u0161ti \u012fvairaus am\u017eiaus pacientams, ta\u010diau tarp vyresnio am\u017eiaus pacient\u0173 yra daug da\u017enesnis. Vienas i\u0161 pirmiausia pa\u017eeid\u017eiam\u0173 \u2013 vir\u0161kinamasis traktas.<\/font><\/span><\/p>\n<p><span lang=\"LT\" style=\"font-family: Arial; mso-ansi-language: LT\"><font size=\"2\"><\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Polifarmacija padidina vaist\u0173 tarpusavio s\u0105veik\u0173 bei nepageidaujam\u0173 reakcij\u0173 pasirei\u0161kimo rizik\u0105. 1 lentel\u0117je i\u0161vardyti vaistai, da\u017eniausiai sukeliantys nepageidaujamas reakcijas vyresnio am\u017eiaus pacientams.<\/p>\n<p><\/span> <span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Vyresnio am\u017eiaus \u017emon\u0117s da\u017enai skund\u017eiasi vir\u0161kinimo sutrikimais. Tam turi \u012ftakos ne tik su am\u017eiumi atsirad\u0119 vir\u0161kinamosios sistemos pakitimai, bet ir gausus vaist\u0173 vartojimas. Dauguma i\u0161vardyt\u0173 vaist\u0173 gali sukelti \u012fvairius vir\u0161kinamojo trakto sutrikimus: pilvo skausm\u0105, pykinim\u0105, v\u0117mim\u0105, viduriavim\u0105, viduri\u0173 u\u017ekiet\u0117jim\u0105 ir kitus (2 lentel\u0117).<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\"><\/p>\n<p><\/span>\u00a0<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\"><img loading=\"lazy\" decoding=\"async\" height=\"184\" width=\"386\" alt=\"Vartojamo didelio vaist\u0173 kiekio poveikis vir\u0161kinamajam traktui\" src=\"\"><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">\u00a0<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\"><img loading=\"lazy\" decoding=\"async\" height=\"277\" width=\"474\" alt=\"Vartojamo didelio vaist\u0173 kiekio poveikis vir\u0161kinamajam traktui\" src=\"\"><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">\u00a0<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">\u00a0<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Yra nema\u017eai preparat\u0173, galin\u010di\u0173 palengvinti \u0161iuos nepageidaujamus poveikius vir\u0161kinamajam traktui. Be abejo, prie\u0161 juos skiriant reik\u0117t\u0173 \u012fvertinti, ar jie nesukels vaist\u0173 s\u0105veikos ir dar labiau nepablogins paciento b\u016bkl\u0117s. Gana da\u017enai pasitaikantys gastrito, padid\u0117jusio r\u016bg\u0161tingumo simptomai gali b\u016bti koreguojami H<\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 6.0pt; mso-ansi-language: LT\">2 <\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">receptori\u0173 blokatoriais, pvz., preparatu <i><a href=\"https:\/\/pasveik.lt\/&lt;a%20href=\" https:>raniberl<\/a>-lengva-pamirsti-remeni\/padidejes-skrandzio-rugstingumas\/12108&#8243;&gt;<a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/raniberl\/5166\">Raniberl<\/a> <\/i>(ranitidinas). Duj\u0173 susikaupimo vir\u0161kinamajame trakte, pilvo p\u016btimo simptomus galima palengvinti preparatu <i><a href=\"https:\/\/pasveik.lt\/&lt;a%20href=\" https:>espumisan<\/a>\/kodel-pucia-pilva\/12083&#8243;&gt;Espumisan <\/i>(<i>simetikonum<\/i>), skiriant po dvi kapsules 3\u20134 kartus per par\u0105. Espumisano veiklioji med\u017eiaga simetikonas yra putojim\u0105 slopinanti med\u017eiaga. Tiek cheminiu, tiek biologiniu po\u017ei\u016briu simetikonas yra visi\u0161kai inerti\u0161kas, tod\u0117l prakti\u0161kai apsinuodyti ne\u012fmanoma. Vyresniame am\u017eiuje da\u017enai pasirei\u0161kian\u010di\u0105 dispepsij\u0105, vir\u0161kinimo sutrikimus galima gydyti dieta, mitybos koregavimu bei vir\u0161kinim\u0105 gerinan\u010diais vaistiniais preparatais <i>Mezym <\/i>(veiklioji med\u017eiaga \u2013 vir\u0161kinimo fermentai lipaz\u0117, amilaz\u0117 bei proteaz\u0117) bei <i><a href=\"https:\/\/pasveik.lt\/vaistai\/pangrol\/5508\">Pangrol <\/a><\/i>(pankreatinas).<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Vieni i\u0161 daugiausiai nepageidaujam\u0173 reakcij\u0173 vir\u0161kinamajam traktui sukelian\u010di\u0173 vaist\u0173 \u2013 NVNU. Juos vartojant gali pasireik\u0161ti <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/viduriavimas-2\/72707\">viduriavimas<\/a>, pykinimas, v\u0117mimas, pilvo skausmas, <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/gastritas\/4354\">gastritas<\/a>, duj\u0173 susikaupimas vir\u0161kinimo trakte, <a href=\"https:\/\/pasveik.lt\/ligos\/&lt;a%20href=\" https:>dispepsija<\/a>\/4503&#8243;&gt;dispepsija, <a href=\"https:\/\/pasveik.lt\/ligos\/&lt;a%20href=\" https:>kraujavimas<\/a>-is-virskinamojo-trakto\/4502&#8243;&gt;<a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/kraujavimas\/43826\">kraujavimas<\/a> i\u0161 vir\u0161kinamojo trakto, <a href=\"https:\/\/pasveik.lt\/ligos\/opalige\/4346\">dvylikapir\u0161t\u0117s \u017earnos bei skrand\u017eio opa <\/a>bei perforacija ir kt.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Opos atsiradimo rizika yra susijusi su NVNU doze: paprastai didesn\u0117 vaisto doz\u0117 didina opos atsiradimo tikimyb\u0119, pvz., piroksikamo atveju. Aspirino keliamos opalig\u0117s rizikos dydis nedaug priklauso nuo to, ar \u0161is vaistas vartojamas \u012fprastin\u0117mis doz\u0117mis, ar ma\u017eomis doz\u0117mis kraujo kre\u0161umui ma\u017einti. NVNU sukelta skrand\u017eio opa bei kiti vir\u0161kinamosios sistemos pa\u017eeidimai gali b\u016bti gydomi \u012fvairiai:<\/p>\n<p><\/span><\/p>\n<ul style=\"margin-top: 0cm\" type=\"disc\">\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Jei op\u0105 suk\u0117lusio NVNU vartojim\u0105 galima nutraukti, m\u0117nesio trukm\u0117s gydymo kurso H<\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 6.0pt; mso-ansi-language: LT\">2 <\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">receptori\u0173 antagonistu, pvz., <i><a href=\"https:\/\/pasveik.lt\/&lt;a%20href=\" https:>raniberl<\/a>-lengva-pamirsti-remeni\/padidejes-skrandzio-rugstingumas\/12108&#8243;&gt;<a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/raniberl\/5166\">Raniberl<\/a> <\/i>(ranitidinu),arba proton\u0173 siurblio inhibitoriumi gali pakakti, kad opa prad\u0117t\u0173 gyti.\n<\/p>\n<p><\/span><\/li>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Jei pakei\u010diamasis analgetinis ar u\u017edegim\u0105 slopinantis gydymas b\u016btinas, galimos kelios i\u0161eitys:\n<\/p>\n<p><\/span><\/li>\n<\/ul>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt 72pt; text-indent: -18pt; text-align: justify; mso-layout-grid-align: none; mso-list: l1 level2 lfo1; tab-stops: list 72.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">&#8211;<span style=\"font: 7pt 'Times New Roman'\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Paracetamolis standartin\u0117mis doz\u0117mis bei re\u017eimas A.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt 72pt; text-indent: -18pt; text-align: justify; mso-layout-grid-align: none; mso-list: l1 level2 lfo1; tab-stops: list 72.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">&#8211;<span style=\"font: 7pt 'Times New Roman'\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Op\u0105 suk\u0117lusio NVNU pakeitimas ma\u017eiausia veiksminga ibuprofeno doze bei gydymo kurso H<\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 6.0pt; mso-ansi-language: LT\">2 <\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">receptori\u0173 antagonistu, pvz., <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/raniberl\/5166\">Raniberl<\/a> <\/i>(ranitidinu) ar proton\u0173 siurblio inhibitoriumi paskyrimas.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt 72pt; text-indent: -18pt; text-align: justify; mso-layout-grid-align: none; mso-list: l1 level2 lfo1; tab-stops: list 72.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">&#8211;<span style=\"font: 7pt 'Times New Roman'\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Pakeisti vartot\u0105 neselektyv\u0173 NVNU selektyviu COX-2 inhibitoriumi (pvz., <a href=\"https:\/\/pasveik.lt\/vaistai\/nimesil\/9841\"><i>Nimesil<\/i>)<\/a>. NVNU sukeltos opalig\u0117s atsiradimo rizika yra ypatingai didel\u0117 vyresniame am\u017eiuje, ir ypa\u010d pacientams, kurie:<\/p>\n<p><\/span><\/p>\n<ul style=\"margin-top: 0cm\" type=\"disc\">\n<ul style=\"margin-top: 0cm\" type=\"disc\">\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none; mso-list: l0 level2 lfo2; tab-stops: list 72.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">reguliariai vartoja aspirin\u0105 (kardioprotekciniais tikslais);\n<\/p>\n<p><\/span><\/li>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none; mso-list: l0 level2 lfo2; tab-stops: list 72.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">kartu su NVNU vartoja ir geriamuosius kortikosteroidus ar antikoaguliantus;\n<\/p>\n<p><\/span><\/li>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none; mso-list: l0 level2 lfo2; tab-stops: list 72.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">anks\u010diau buvo skrand\u017eio opa.\n<\/p>\n<p><\/span><\/li>\n<\/ul>\n<\/ul>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Rizika gali b\u016bti beveik perpus suma\u017einta profilakti\u0161kai vartojant H<\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 6.0pt; mso-ansi-language: LT\">2 <\/span><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">receptori\u0173 antagonistus, pvz., <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/raniberl\/5166\">Raniberl<\/a> <\/i>(ranitidin\u0105).<\/p>\n<p><\/span> <span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Vyresniame am\u017eiuje atsiradusi\u0173 fiziologini\u0173 organizmo poky\u010di\u0173 d\u0117ka bei d\u0117l didelio vartojamo vaist\u0173 kiekio da\u017enai pasirei\u0161kia \u012fvair\u016bs vir\u0161kinamojo trakto sutrikimai bei pa\u017eeidimai. Dalies j\u0173 galima i\u0161vengti atid\u017eiau parenkant vaistinius preparatus, stengiantis skirti kuo ma\u017eiau preparat\u0173 vienu metu bei vengiant vaist\u0173 s\u0105veikos. Ta\u010diau nepageidaujamo vaist\u0173 poveikio vir\u0161kinamajam traktui ne visuomet pavyksta i\u0161vengti. Tokiais atvejais galima suma\u017einti nepageidaujam\u0105 reakcij\u0105 suk\u0117lusio vaisto doz\u0119 ar nutraukti jo vartojim\u0105 bei skirti preparat\u0173 vir\u0161kinamajam traktui gydyti.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><b><i><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 9.0pt; mso-ansi-language: LT\">\u00a0<\/p>\n<p><\/span><\/i><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><b><i><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 9.0pt; mso-ansi-language: LT\">Pareng\u0117 Vaistinink\u0117 Justina Penkauskait\u0117<\/p>\n<p><\/span><\/i><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">\u00a0<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">\u017durnalas \u201cGydymo menas\u201d<\/p>\n<p><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p style=\"text-align: justify\"><span lang=\"LT\" style=\"font-family: Arial; mso-ansi-language: LT\"><font size=\"2\">Vyresnio am\u017eiaus pacientai daug da\u017eniau serga \u012fvairiomis ligomis ir gydosi keletu skirting\u0173 vaist\u0173. Polifarmacija gali pasireik\u0161ti \u012fvairaus am\u017eiaus pacientams, ta\u010diau tarp vyresnio am\u017eiaus pacient\u0173 yra daug da\u017enesnis. Vienas i\u0161 pirmiausia pa\u017eeid\u017eiam\u0173 &ndash; vir\u0161kinamasis traktas.<\/font><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[39,832,870,138,923,55],"site":[],"post_item_type":[27345],"class_list":["post-12079","post","type-post","status-publish","format-standard","hentry","tag-dieta","tag-nvnu","tag-opos","tag-vaistai","tag-veiklioji","tag-virskinimo"],"acf":{"post_sites":false},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/12079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/comments?post=12079"}],"version-history":[{"count":0,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/12079\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media?parent=12079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/categories?post=12079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/tags?post=12079"},{"taxonomy":"site","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/site?post=12079"},{"taxonomy":"post_item_type","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/post_item_type?post=12079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}